Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Overcoming Obstacles in AAV Viral Vector Manufacturing
View All Featured ArticlesHeadline News
Petosemtamab combination cuts risk of death by 50% in Phase III head and neck cancer trial
Roche receives CE Mark for compact cobas smart e immunoanalyser
Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Control Strategy and a Real Time Release Testing From a Development Line to Commercial Manufacturing
Presented by Tom Van Den Kerkhof Scientist at Johnson & Johnson and Sebastian Sowinski Key Account Manager at Sentronic
25th March 2020
Digitally Transforming Pharmaceutical Process Development and Manufacturing: Enabling Technologies for a Sustainable Future
Presented by Moiz Diwan, Moiz Diwan, Ph.D. Process Research and Development, AbbVie Inc., North Chicago, IL
04th October 2022
Making continuous processing a reality in the pharmaceutical industry
Presented by Mark Gibson Associate Director, Drug Product Manufacture & Delivery for AstraZeneca and Marcel de Matas, Principal Scientist at AstraZeneca
21st August 2013
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Amsphere TM A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















